Bristol-Myers Squibb logo

Bristol-Myers Squibb

Stock
Stock
Ticker: BMY
BMY

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Bristol-Myers Squibb has so far distributed $0.63 in 2026. The next dividend will be paid on 01.05.2026


$1.264

CHART BY

Frequently asked questions

What is Bristol-Myers Squibb's market capitalization?

The market capitalization of Bristol-Myers Squibb is $126.20B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Bristol-Myers Squibb's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Bristol-Myers Squibb is 17.92. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Bristol-Myers Squibb?

Bristol-Myers Squibb's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $3.459. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Bristol-Myers Squibb's stock?

Currently, 30 analysts cover Bristol-Myers Squibb's stock, with a consensus target price of $59.45. Analyst ratings provide insights into the stock's expected performance.

What is Bristol-Myers Squibb's revenue over the trailing twelve months?

Over the trailing twelve months, Bristol-Myers Squibb reported a revenue of $48.19B.

Financials

Market Cap 
$126.20B
EPS (TTM) 
$3.459
P/E ratio (TTM) 
17.92
Revenue (TTM) 
$48.19B

Pricing

1D span
$58.77$62.01
52W span
$42.52$63.33

Analyst Ratings

The price target is $59.45 and the stock is covered by 30 analysts.

Buy

11

Hold

18

Sell

1

Information

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Industries
Major Pharmaceuticals
Sector
Health Care

Identifier

Primary Ticker
BMY

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation